WCG Insights Home » Home » Understanding the Challenges of Managing Combination Product Safety Reporting
Other content in this Stream
The Eligibility Conundrum in Clinical Trial Protocols: FDA Issues Workshop Report
Solving the Problem of Clinical Research Enrollment
Written Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?
Avoid Enrollment Pitfalls: Find Your Best-fit Clinical Trial Sites
Selecting the right site is the single most crucial decision you’ll make about your next clinical trial. And perhaps the single most important consideration in selecting a site is whether it can make
Rare & Orphan Disease Endpoints: Challenges & Examples from Neurodevelopment
Subject Recruitment Materials: Understanding the Requirements for IRB Review
Often, the only way for potential research subjects to learn about a clinical trial is through recruitment materials. But what materials must you submit to the IRB for review?
WCG Overview Video
Six Practices of High Performing Clinical Research Sites
Learn what high-performing research sites have in common, and what makes sponsors return to them again and again.
Recruiting Patients & Time Management: Top Tips for Dealing with the Most Critical Resource in Research
Learn how to engage sites more effectively with the appropriate recruitment resources, use dedicated staff to manage recruitment efforts, and eliminate bottlenecks and expedite recruitment timelines.
Case Study: Merck Site Selection & Feasibility Technology
Five Essential Considerations for Efficient Site Contracts and Payments
Shifting the Tide of Inefficient Site Contract Negotiations: Turn to an Expert
How Roche Optimized its Global Safety Reporting Process for Clinical Trials
Roche recognized several major challenges that its CTSP 2.0 system needed to address.
Rare Disease Case Study: Familial Amyloidosis
Our client, a top-tier CRO, was faced with the challenge of enrolling for a non-interventional screening study in the familial amyloidotic cardiomyopathy (FAC) patient population.
Personalized Medicine Requires Personalized Measurement
Looking Ahead to 2018: Insights into Clinical Research Trends from Our Experts
In this paper, WCG thought-leaders provide insights on what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
Solving The Problem of Clinical Research Enrollment
Examine the conditions that affect enrollment and learn strategies to increase it.
Strategies that Inform Investigator Selection and Enhance Enrollment
Learn how to use predictive analytics and strategic consulting to guide site selection and enrollment success.
Investigational Drugs Outside of Clinical Trials - Understanding Expanded Access and Right-to-Try
Addressing Placebo Response